1. Home
  2. MMU vs DRTS Comparison

MMU vs DRTS Comparison

Compare MMU & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Managed Municipals Fund Inc.

MMU

Western Asset Managed Municipals Fund Inc.

HOLD

Current Price

$10.45

Market Cap

567.5M

Sector

Finance

ML Signal

HOLD

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$7.33

Market Cap

546.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMU
DRTS
Founded
1992
2015
Country
United States
Israel
Employees
N/A
125
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
567.5M
546.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MMU
DRTS
Price
$10.45
$7.33
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.67
AVG Volume (30 Days)
92.5K
267.7K
Earning Date
01-01-0001
03-09-2026
Dividend Yield
4.92%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,055.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.46
$2.30
52 Week High
$10.71
$8.60

Technical Indicators

Market Signals
Indicator
MMU
DRTS
Relative Strength Index (RSI) 38.15 52.12
Support Level $10.41 $6.37
Resistance Level $10.45 $7.77
Average True Range (ATR) 0.06 0.44
MACD -0.01 -0.00
Stochastic Oscillator 5.00 66.11

Price Performance

Historical Comparison
MMU
DRTS

About MMU Western Asset Managed Municipals Fund Inc.

Western Asset Managed Municipals Fd Inc is a non-diversified, closed-end management investment company. Its investment objective is to maximize current income exempted from federal income tax as is consistent with the preservation of principal. The fund predominantly invests in long-term investment grade municipal debt securities issued by state and local governments, political subdivisions, agencies, and public authorities (municipal obligations).

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.

Share on Social Networks: